FindTrial
Sign In

Pharmacokinetic Clinical Reaserch of EVG/COBI/FTC/TAF FDC -Food effect on Pharmacokinetic Profiles in Japanese Healthy Adult Male Volunteers-

Pharmacokinetic Clinical Reaserch of EVG/COBI/FTC/TAF FDC -Food effect on Pharmacokinetic Profiles in Japanese Healthy Adult Male Volunteers-

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1080223252
Enrollment
12
Registered
2016-06-28
Start date
2016-06-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Null

Interventions

investigational material(s) Generic name etc : EVG/COBI/FTC/TAF INN of investigational material : Therapeutic category code : 625 Anti-virus agents Dosage and Administration for Investigational mater

Sponsors

TORII PHARMACEUTICAL CO., LTD.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) Healthy Japanese male aged between 20 and 45 years inclusive at obtaining informed consent (2) Body mass index ([body weight (kg)] / [height (m)]2) of 18.5 to less than 25.0 at the screening tests (3) Written informed consent for participation in the study

Exclusion criteria

Exclusion criteria: (1) Subject with history of serious disorder affecting the brain, liver, kidneys, heart, lungs, gastrointestine, hematological system, endocrine system, psychiatrics, or others (2) Deviation from the pre-defined reference values of blood pressure, pulse rate, or ECG

Design outcomes

Primary

MeasureTime frame
plasma drug concentration—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026